Roche Gains Novel Anticancer Antibody Product
By Helen Scrutton
Pharma Deals Review: Vol 2008 Issue 97 (Table of Contents)
Published: 18 Jun-2008
DOI: 10.3833/pdr.v2008.i97.166 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Roche has entered into a deal for TB-403, a novel anticancer agent jointly developed by BioInvent International and ThromboGenics...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS